Dong, Yunzhu
Zhao, Xinghui
Feng, Xiaomin
Zhou, Yile
Yan, Xiaomei
Zhang, Ya
Bu, Jiachen
Zhan, Di
Hayashi, Yoshihiro
Zhang, Yue
Xu, Zefeng
Huang, Rui
Wang, Jieyu
Zhao, Taoran
Xiao, Zhijian
Ju, Zhenyu
Andreassen, Paul R.
Wang, Qian-fei
Chen, Wei
Huang, Gang
Funding for this research was provided by:
National Natural Science Foundation of China (grant 81470297, grant 81770129, 81471911, grant 81471911)
Foundation for the National Institutes of Health (R21CA187276)
Cincinnati Children's Hospital Research Foundation the Leukemia Research Foundation the OCRA
the Cincinnati Children's Hospital Research Foundation
Personalized Medicines--Molecular Signature-based Drug Discovery and Development Strategic Priority Research Program of the Chinese Academy of Sciences
Article History
Received: 29 May 2018
Revised: 27 February 2019
Accepted: 13 March 2019
First Online: 9 April 2019
Compliance with ethical standards
:
: The authors declare no potential conflicts of interest.